(818) 431-5208

info@mahealthcareadvisors.com

REFERRAL PROGRAM

BUYER REGISTRATION
  • WHO WE ARE
  • SERVICES
    • Sell Your Company
    • M&A Consultation
    • Expert Valuations
    • Broker-Dealer
  • TRANSACTIONS
  • INSIGHTS
    • The Selling Process
    • The M&A Market
    • M&A Insights Podcast
  • PRESS
  • CONTACT US

Press

We Manage the Sale Process, So You Can Manage Your Business


Press

M&A Healthcare Advisors Announces Sale of Gallaher Plastic Surgery & Med Spa to Olympus Cosmetic Group

M&A Healthcare Advisors advised Gallaher Plastic Surgery & Med Spa on its sale to Olympus Cosmetic Group. M&A Healthcare Advisors

September 8, 2026
Read More
Press, The M&A Market

Trump’s Executive Order Reversal: Potential Shifts in Home-Care M&A Landscape

At M&A Healthcare Advisors, we closely monitor regulatory changes that influence transaction strategy and valuation in the healthcare sector. In

August 18, 2025
Read More
Pharmacy Successful Transaction
Press

M&A Healthcare Advisors Represents Greater Boston Long Term Care Pharmacy In Their Sale to Tarrytown Expocare Pharmacy

“Working with the Greater Boston Long Term Care Pharmacy team was a privilege. It was also a nice milestone for

January 13, 2025
Read More
Press

UnitedHealth and Amedisys Defend $3.3 Billion Merger Amid DOJ Lawsuit

As Andre Ulloa, founder and managing director at M&A Healthcare Advisors, told Modern Healthcare, he believes the Justice Department under

November 19, 2024
Read More
Press

Insights into July 2024 Healthcare M&A Trends with Levin Associates

“We believe that Home Health and Hospice will continue to be targeted, particularly in the lower middle market; expect this

August 7, 2024
Read More
M&A Healthcare Advisors
Press

M&A Healthcare Advisors Achieves New Milestone

Table Of Contents Enhancing Services for the Healthcare Industry Expanded Services Commitment to Excellence Strategic Growth and Client Support Commitment

August 2, 2024
Read More
Press

Navigating the Impact of Medicaid’s 80/20 Rule on Home Care M&A Trends

​Medicaid’s new 80/20 rule could accelerate consolidation across the home care industry. Smaller providers may face increased financial pressure as

May 22, 2024
Read More
Press

Insights On Walmart’s Shift From Andre Ulloa

In the aftermath of Walmart's decision to discontinue its health and virtual care delivery products, Andre Ulloa, Founder and Executive

May 8, 2024
Read More
Press

Walgreens’ Setback and VillageMD’s Clinic Closures: What Does It Mean?

In recent news, Walgreens Boots Alliance, a major player in the healthcare industry, disclosed a significant development affecting its healthcare

April 3, 2024
Read More
Press

Deciphering the Health Clinic Market: Insights from M&A Advisors

In an enlightening discussion with Levin Associates, Andre Ulloa, Partner and Executive Advisor at M&A Healthcare Advisors, explored the intricacies

March 30, 2024
Read More
Load More

(818) 431-5208

info@mahealthcareadvisors.com

4500 Park Granada Blvd. Suite 202
Calabasas, CA 91302
  • About
  • Sell Your Company
  • Careers
  • CONTACT US

Securities are offered through Finalis Securities LLC Member FINRA / SIPC. M&A Healthcare Advisors is not a registered broker dealer, and Finalis Securities LLC and M&A Healthcare Advisors are separate, unaffiliated entities. Finalis Securities LLC, Office of Supervisory Jurisdiction is located at 450 Lexington Ave, New York, NY 10017, 800-962-0418.

Copyright 2026 M&A Healthcare Advisors, all rights reserved.

Market Research

The first step in any valuation is to explore what drives value within your specific market segment. In the healthcare sector, understanding industry trends and identifying key market drivers is essential to understanding what makes your business unique.

  • Industry Trends: The healthcare landscape is constantly evolving. Factors such as regulatory changes, technological advancements, reimbursement risk, skilled caregiver supply, and shifts in patient demographics can significantly impact your business’s value. Staying ahead of these trends and adapting your operations accordingly can make your company more attractive to potential buyers in the market.
  • Key Market Drivers: Patient outcomes, cost-efficiency, and specialized services are often critical value drivers in the eyes of a potential acquirer. For example, a company with a track record of delivering better patient outcomes or offering services that are currently in high demand can be factors which elevate your perceived valuation.
  • Identifying Competition and Market Position: Benchmarking your business against competitors or other operator profiles can provide a clearer picture of your market position. This involves analyzing competitor strengths, weaknesses, and growth strategies to highlight your company’s competitive advantage.

Transaction Comparatives

Once we have a solid understanding of your market, we move on to examining recent transactions in the healthcare sector to identify valuation benchmarks.

  • Assessing Comparable Transactions: By analyzing similar deals, we identify comparable businesses that have recently gone through an M&A transaction. This helps us understand the market’s value expectations for companies that operate with a similar profile to your business. While every business is unique, one of the most effective ways to estimate the value of your business is through benchmarking your company with similar companies who have sold in the open market.  With our extensive experience in healthcare M&A, we have transactional comparative data t relative to your business.
  • Market Multiples: One of the key metrics utilized in M&A is the Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) multiple. EBITDA multiples can offer insight into the value of your business based on its profitability. For example, if comparable companies were recently acquired between 5x – 7x EBITDA, this will be one of the reference points we will utilize in determining our opinion of value.
  • Case Study: We’ll also look at recent acquisitions of companies operating in the same segment and size as you. By examining common valuation drivers, financial metrics, and EBITDA multiples, we can draw parallels to your business and refine our opinion of value further.

Financial Analysis

Once we have market and transactional insights, it’s time to perform a detailed analysis of your business’s financial health and growth prospects.

  • Reviewing Financial Health: We analyze key metrics like revenue growth, profit margins, and operating efficiency to assess how well your business is and has been performing. Consistent (or growing) financials can not only boost your valuation in the market but also demonstrate to buyers that your company is a stable and profitable investment.
  • Impact of Assets and Liabilities: Your business’s assets—such as licenses, medical equipment, inventory, entitled real estate, and proprietary technology— may play a role in determining its value. In certain segments, like behavioral health—substance use disorder clinics, it is vital that out-of-network groups have a standardized marketing system for patient acquisition. Conversely, liabilities like outstanding penalties, reimbursement claw backs, charting/clinical data deficiencies, or restrictive contractual obligations can impact the final valuation.  For example, in hospice it is important to have a program to reduce your cap liability and ensure that all patient charts are completed per the current regulatory standards.
  • Projections and Future Cash Flows: In M&A, it’s not just about your current financials; it’s about where your business is headed. We develop grounded financial projections based on current market conditions, historical performance, and growth potential to demonstrate your company’s future cash flow potential.

Conclusion & Findings

After conducting market research and a thorough analysis of your businesses operational, clinical, and financial performance, we compile our findings to deliver a comprehensive valuation reports.

  • Presenting a Valuation Opinion: We summarize all of the data gathered to provide you with a clear opinion of your business’s value. This valuation is supported by concrete data and expert analysis, ensuring transparency and credibility.
  • Next Steps: Once you have a solid understanding of your company’s value, you’ll be in a strong position to pursue your M&A goals. Whether you’re looking to sell now or later, knowing your valuation allows you to plan your next moves more strategically.

Understanding the process of valuation a healthcare company in today’s market is essential if you’re considering any type of capital event in the near future. By exploring key market drivers, examining recent transactions, conducting a thorough financial analysis, and delivering a well-supported valuation, you can approach any M&A related event with confidence.

Going through the steps of conducting a formal valuation not only helps you gain a clear picture of your company’s worth but also provides you with the opportunity to reach maximum value when entering the market to sell or raise capital. Having a third-party, data-driven analysis can equip you with the information and knowledge to successfully navigate a sale process. At M&A Healthcare Advisors, our goal is to guide you through every step of the way, so you can focus on what matters most—growing and transitioning your business successfully.